PEDIATRICS Vol. 36 No. 1 July 1965, pp. 145-146
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CORIELL, L. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CORIELL, L. L.

Letters to the Editor

LEWIS L. CORIELL M.D.

All Physicians share Dr. Musiker's concern for the deaths, permanent CNS damage, and pyogenic complications caused by measles each year. Unfortunately, little could be done about it up until the very recent months. Experimental vaccines have been in the process of development since 1960 but were first endorsed for general use by the Ad Hoc Advisory Committee to the Surgeon General on Measles Control on February 25, 1963. Use of the vaccine was promptly endorsed by the American Academy of Pediatrics, the American Medical Association and other public health agencies.